Lymphangiomas are relatively uncommon head and neck region lymphatic malformations. Although surgery can be still considered the mainstay of treatment, sclerotherapy by OK-432 is becoming a widespread treatment option. The aim of this article is to present and discuss the management and outcomes of a series of cases of lymphangiomas.
All patients with lymphangiomas who were treated from 2010 to 2018 were reviewed. The following data were recorded: age, gender, subtype, staging, type of treatment, outcome, and recurrence.
Fifteen patients (9 females, 6 males) were included with 2 microcystic and 13 macrocystic lymphangiomas. Six patients underwent surgery with excision (5 with a complete success, one with a fair success), whereas the remaining 9 subjects underwent sclerotherapy by OK-432 (6 with a complete success, 3 with a fair success). No postoperative complications were observed.
All modes of treatment are important in properly selected patients affected by lymphangiomas. OK-432 therapy is a safe and effective option in the treatment of head and neck lymphangiomas.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Balakrishnan K, Perkins J (2012) Management of head and neck lymphatic malformations. Facial Plast Surg 28:596–602
Efe N, Altas E, Mazlumoglu MR, Aktan B, Ucuncu H, Eren S, Oner F (2016) Excellent result with the use of single-dose OK-432 in cervical macrocystic lymphangioma. J Craniofac Surg 27:1802–1803
Gilony D, Schwartz M, Shpitzer T, Feinmesser R, Kornreich L, Raveh E (2012) Treatment of lymphatic malformations: a more conservative approach. J Pediatr Surg 47:1837–1842
Hamoir M, Plouin-Gaudon I, Rombaux P, Francois G, Cornu AS, Desuter G, Clapuyt P, Debauche C, Verellen G, Beguin C (2001) Lymphatic malformations of the head and neck: a retrospective review and a support for staging. Head Neck 23:326–337
Lerat J, Mounayer C, Scomparin A, Orsel S, Bessede JP, Aubry K (2016) Head and neck lymphatic malformation and treatment: clinical study of 23 cases. Eur Ann Otorhinolaryngol Head Neck Dis 133:393–396
Mitsukawa N, Satoh K (2012) New treatment for cystic lymphangiomas of the face and neck: cyst wall rupture and cyst aspiration combined with sclerotherapy. J Craniofac Surg. 23:1117–1119
Ohta N, Fukase S, Watanabe T, Ito T, Aoyagi M (2010) Effects and mechanism of OK-432 therapy in various neck cystic lesions. Acta Otolaryngol 130:1287–1292
Golinelli G, Toso A, Borello G, Aluffi P, Pia F (2015) Percutaneous sclerotherapy with OK-432 of a cervicomediastinal lymphangioma. Ann Thorac Surg 100:1879–1881
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Aluffi Valletti, P., Brucoli, M., Boffano, P. et al. A single-center experience in the management of head and neck lymphangiomas. Oral Maxillofac Surg 24, 109–115 (2020). https://doi.org/10.1007/s10006-020-00832-z
- Maxillofacial malformation
- Plastic surgery
- Head and neck